Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and other GLP-1 receptor agonists are designed to be administered as subcutaneous injections—meaning the needle reaches the fatty tissue layer just under your skin, not deeper muscle tissue. This delivery method allows the medication to absorb slowly into your bloodstream at a steady rate, providing sustained appetite suppression and metabolic benefits throughout the week.
Why Subcutaneous Injection Into Fat Tissue Matters
Subcutaneous injection deposits medication into the adipose tissue layer between your skin and muscle. This anatomical location creates an ideal depot for slow, consistent absorption—a process called depot kinetics. When semaglutide reaches fatty tissue, it enters the bloodstream gradually over several days, maintaining stable drug levels and reducing the risk of side effects from rapid spikes.
The subcutaneous route differs from intramuscular injection, which reaches muscle and causes faster absorption. Slower absorption from fat tissue means longer-lasting medication activity, which explains why semaglutide works as a once-weekly injection rather than requiring daily doses. This pharmacokinetic advantage directly supports consistent appetite reduction and metabolic changes needed for sustained weight loss.
Research shows that proper subcutaneous placement improves medication bioavailability—the amount of drug that actually enters your circulation. Poor injection technique, such as injecting too superficially or into muscle, can reduce bioavailability by 20-30%, meaning you may not receive the full therapeutic effect of your dose.
Approved Injection Sites for Semaglutide Administration
Four primary body areas are approved for semaglutide subcutaneous injection: the abdomen (belly), upper arm, thigh, and buttocks. Each site has adequate subcutaneous fat to accommodate the medication, though the abdomen typically has the thickest fat layer, making it the easiest location for patients new to self-injection. The upper arm and thigh are equally suitable alternatives if you prefer rotating sites.
Site rotation is essential for long-term treatment success. Injecting repeatedly into the same small area can cause lipohypertrophy—thickened or hardened fat deposits that reduce medication absorption. By rotating among your four approved sites each week, you maintain consistent drug delivery and prevent tissue damage. A simple rotation pattern might be: abdomen week 1, upper arm week 2, thigh week 3, buttocks week 4, then repeat.
Within each body area, you should also rotate the specific injection point by at least one inch from your previous injection. This micro-rotation prevents localized tissue trauma and maintains healthy subcutaneous tissue for continuous medication absorption throughout your treatment course.
Proper Injection Depth and Needle Angle Technique
A standard 4mm or 6mm needle on a semaglutide pen reaches the subcutaneous fat layer when inserted at a 90-degree angle (straight into the skin). This needle length is calibrated to penetrate the epidermis and dermis, then deposit medication in the subcutaneous space without reaching muscle underneath. Using the correct needle length is critical—longer needles risk intramuscular injection, while shorter needles might deposit medication too superficially.
To inject properly, pinch a fold of skin and fat between your thumb and fingers, creating a raised area at least one inch thick. Insert the needle straight down through this pinched fold at a 90-degree angle with one smooth, confident motion. Many patients find this easier than at shallow angles because the perpendicular approach ensures consistent depth. After inserting the needle fully, hold it in place for 3-5 seconds before pressing the injection button to allow medication to disperse into the tissue.
After injection, remove the needle while still pinching the skin, then release the pinch and apply gentle pressure for 5-10 seconds with a cotton swab or gauze. Avoid rubbing the injection site, which can cause medication to leak back out or distribute unevenly. If you see blood or notice immediate bruising, that typically indicates you hit a small blood vessel—not dangerous, but it may reduce absorption slightly. This is why rotating sites prevents repeated vascular trauma.
How PlexusDx Supports Your Injection Success
PlexusDx compounded semaglutide injection begins at $149 per month and arrives with detailed injection instruction materials, including illustrated guides showing approved sites and proper needle angle. Because each prescription comes from a licensed 503A compounding pharmacy, PlexusDx can provide dosing flexibility—your dose may need to increase over time, but your price remains flat. This means you never pay more per unit as your clinician optimizes your dose for maximum effect.
All PlexusDx patients receive personalized clinical guidance during their initial consultation, including a walkthrough of injection technique specific to their body type and comfort level. For patients interested in understanding whether genetic factors influence their response to semaglutide, PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway genetic analysis that maps 14 metabolic pathways and 150+ insights related to GLP-1 receptor sensitivity, appetite regulation genes like MC4R, and fat metabolism variants. This test, available as a $99 add-on after your first month, helps your clinician personalize your dose trajectory and medication choice.
PlexusDx serves all 50 states without insurance requirements or membership fees, and all medications are HSA and FSA eligible. Whether you choose compounded semaglutide injection, oral semaglutide, or dual-compound options like GLP-Squared, proper injection technique ensures you receive the full benefit of your personalized therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What happens if I inject semaglutide into muscle instead of fat?
Intramuscular injection causes faster, less predictable absorption, which can increase side effects like nausea and may reduce the medication's overall effectiveness. Always aim for subcutaneous fat tissue using the pinch-and-inject technique at a 90-degree angle to ensure proper depot absorption.
Can I inject semaglutide in the same spot every week?
No. Repeated injection into the same site causes lipohypertrophy—hardened fat deposits that impair medication absorption. Rotate among your four approved body areas and use different injection points within each area by at least one inch to maintain consistent drug delivery.
Does PlexusDx provide injection training or support?
Yes. PlexusDx compounded semaglutide ($149/mo) includes detailed injection guidance during your initial consultation and written instructions with your prescription. Our team walks you through proper technique, site rotation, and troubleshooting before you self-inject at home.
Is bruising after a semaglutide injection normal or dangerous?
Minor bruising is common and usually harmless—it indicates you may have hit a small blood vessel. However, it can slightly reduce absorption at that injection site. Bruising typically resolves in 1-2 weeks and is prevented by rotating injection sites and applying gentle pressure after injection without rubbing.
How does the Precision Peptide Genetic Test help with injection success?
PlexusDx's $99 genetic test analyzes GLP1R variants (rs6923761) and other appetite-regulation genes to predict your individual response to semaglutide. This information helps your clinician optimize your specific dose and injection frequency for faster results, complementing proper injection technique.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can Wegovy Pens Be Thrown in Trash? Your Essential Guide to Safe Disposal
Unlocking Weight Loss Potential with Zepbound